Snowden Capital Advisors LLC Neurocrine Biosciences Inc Transaction History

Snowden Capital Advisors LLC

$3.12 Billion
Q4 2024

A detailed history of Snowden Capital Advisors LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 5,949 shares of NBIX stock, worth $717,984. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,949

Previous 5,867 1.4%

Holding current value

$717,984

Previous $675,000 20.3%

% of portfolio

0.03%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$111.62 - $139.44 $9,152 - $11,434	82 Added 1.4%	5,949 $812,000
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $504,610 - $674,472	-4,404 Reduced 42.88%	5,867 $675,000
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $13,086 - $14,319	-100 Reduced 0.96%	10,271 $1.41 Million
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $60,114 - $66,264	-461 Reduced 4.26%	10,371 $1.43 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $67,990 - $85,099	641 Added 6.29%	10,832 $1.43 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $6,299 - $7,845	67 Added 0.66%	10,191 $1.15 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $467,973 - $548,155	5,227 Added 106.74%	10,124 $954,000
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $7,340 - $9,595	78 Added 1.62%	4,897 $495,000
Q4 2022 Feb 13, 2023	SELL	$106.72 - $127.06 $67,340 - $80,174	-631 Reduced 11.58%	4,819 $575,000
Q3 2022 Nov 09, 2022	BUY	$92.03 - $107.81 $118,810 - $139,182	1,291 Added 31.04%	5,450 $578,000
Q2 2022 Aug 12, 2022	BUY	$75.79 - $100.07 $315,210 - $416,191	4,159 New	4,159 $405,000
Q3 2021 Feb 05, 2024	SELL	$86.18 - $99.03 $557,929 - $641,120	-6,474 Reduced 63.53%	3,717 $356 Million
Q2 2021 Jan 08, 2024	BUY	$89.43 - $102.27 $257,021 - $293,923	2,874 New	2,874 $280 Million
Q1 2020 Jan 08, 2024	SELL	$75.11 - $113.76 $4.16 Million - $6.3 Million	-55,400 Closed	0 $0
Q4 2019 Jan 08, 2024	BUY	$86.8 - $118.57 $520,800 - $711,420	6,000 Added 12.15%	55,400 $59.5 Million
Q3 2019 Jan 08, 2024	BUY	$83.82 - $101.5 $3.29 Million - $3.98 Million	39,209 Added 384.74%	49,400 $44.5 Million

Others Institutions Holding NBIX

# of Institutions

654

Shares Held

96.5M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Neurocrine Biosciences Inc Transaction History